Viral Vector Process Development Summit
Evvnt Promotion / evvnt
Archivio
31.01.2023 - 02.02.2023 Omni Parker House, 60 School Street, 02108 Boston, Massachusetts, USA
Time: 9:00 am - 4:30 pm
Temi della conferenza
As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability.
As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
URL:
Website: https://go.evvnt.com/1322215-3?pid=4832
Speakers: Rajiv Gangurde | Chief Technology Officer | SparingVision, Susan D'Costa | Executive VP and Global Head, Technology | Alcyone Therapeutics, and more.
URL:
Website: https://go.evvnt.com/1322215-3?pid=4832
Speakers: Rajiv Gangurde | Chief Technology Officer | SparingVision, Susan D'Costa | Executive VP and Global Head, Technology | Alcyone Therapeutics, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/1322215-2?pid=4832
Ms. Stephanie Nketia
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
